Gala vs. Embody NAD+: injections, nasal spray and clinician support

Gala and Embody both offer clinician-prescribed NAD+ injections. The differences that can change your choice are a needle-free option, the support you receive after intake and what the first three months cost.

Quick verdict

Embody is the first one to look at if you want a needle-free option or a care coach. It offers a nasal spray alongside its compounded injection. If you already know you want an at-home injection and prefer a written intake with a predictable review schedule, Gala spells out that experience, including a quarterly check-in. Neither provider presents a head-to-head clinical study that would justify choosing its product for better energy or memory. [1] · [2] · [3]

Gala and Embody at a glance

Gala and Embody compared on the same four questions

Your priority	Gala NAD+	Embody NAD+
If I prefer to avoid injections [1] · [2] · [3]	Gala describes an injection you give yourself under the skin. Its NAD+ listing offers one format.	Embody also lists a prescription nasal spray at the same advertised price as its injection. A clinician determines which option is appropriate.
What do I know about the injection? [1] · [2] · [3]	Your provider sets the dose. Gala’s public offer gives no vial concentration or quantity in milligrams.	Embody identifies its injection as compounded and lists 500–1,000 mg options. That range alone tells you neither the concentration nor how much you would take per injection.
Who helps me after I start? [1] · [3]	A licensed provider reviews your written intake. Gala describes a quarterly questionnaire to continue care.	Embody includes a care coach for ongoing support and a licensed clinician for prescription review and dose adjustments as needed.
What will three months cost? [1] · [2]	$357 at the advertised three-month rate of $119/month. The shorter offer starts at $149 for a 28-day supply.	$247 at the advertised promotional rate of $49 for month one and $99 for each of the next two months.

What would the extra $110 buy at Gala?

At the published rates, Gala’s three-month plan works out to $119 × 3 = $357. Embody’s promotional schedule works out to $49 + $99 + $99 = $247. Both include clinician review and shipping. The extra $110 puts you in Gala’s stated quarterly review program. The public offers give no basis for attributing that premium to a stronger formulation or a better outcome. These are advertised three-month totals, before any individual change in plan. [1] · [2] · [3]

What support looks like between orders

Imagine you have a question about your prescription in week three. Embody explicitly includes ongoing coaching and assigns dose decisions to a clinician. Gala explains when its next routine clinical review happens. Its NAD+ page leaves the response time for a question between reviews open. If access between appointments matters to you, Embody describes more of that service up front. We did not test either provider’s response time. [1] · [3]

Will either program improve energy or slow aging?

We found no direct comparison showing that Gala or Embody produces better results. A 2026 systematic review found no eligible outcomes trials of intravenous or intramuscular NAD+ for anti-aging or wellness. Those routes differ from Gala’s under-the-skin injection and Embody’s nasal spray. The review gives us no basis for promising an energy, memory or longevity benefit from either offer. [1] · [2] · [4]

Pharmacy information matters for an injectable. FDA reported reactions after some NAD+ injections and warned about ingredients unsuitable for preparing sterile drugs. The notice does not identify either program. Embody lists several pharmacy partners, so the list alone cannot establish which one would prepare your prescription. Ask the prescribing clinician to identify the dispensing pharmacy and explain the expected benefits and risks for your situation. [2] · [5]

Frequently asked questions

Which NAD+ program should I look at first?

We Tried It All recommends looking at Embody first if you want to discuss a nasal option or ongoing coaching. Gala lays out the clearer routine for someone comfortable with a home injection who wants written intake and scheduled quarterly reviews.

Does Embody’s 500–1,000 mg listing mean its injection is stronger?

The listing does not give a comparable dose for the two programs. To compare what is actually prescribed, you would need the concentration in mg/mL and the prescribed volume per injection from each provider. A larger amount on a vial can simply mean it contains more doses.

Are the injection and nasal spray interchangeable?

Embody lists both at the same price. Its offer does not provide a head-to-head study showing equivalent effects or equivalent doses. If avoiding needles matters to you, the nasal option is a reason to discuss Embody with a clinician.

Does a clinician-reviewed offer establish that an injection is approved?

No. FDA has reported adverse events associated with injectable NAD+ products and warned compounders about unsuitable ingredients for sterile preparations. Marketing claims and an online intake cannot resolve those questions.

Does the label “one month” mean there is no automatic renewal?

No. Supply duration and subscription enrollment are separate terms. Ask for the next billing date and cancellation process before authorizing a charge.

What was FDA’s concern about ingredients?

FDA warned that food-grade materials can be unsuitable for preparing sterile drugs without appropriate processing because contamination can include microbes or endotoxins. A purity statement alone does not resolve that issue.

Sources

1. Gala’s NAD+ program
2. Embody’s NAD+ program
3. Embody’s injection offer
4. 2026 clinical evidence review
5. FDA notice on injectable NAD+